July 27, 2011
MENLO PARK, Calif. - An international team of scientists has successfully employed single molecule, real-time (SMRT™) DNA sequencing technology from Pacific Biosciences of California, Inc. (NASDAQ:PACB) to provide valuable insights into the pathogenicity and evolutionary origins of the highly virulent bacterium responsible for the German E. coli outbreak. Published online today in the New England [...]
NextGen Sciences Launches Multiplex Protein CSF Biomarker Assay for Multiple Sclerosis
July 27, 2011
Ann Arbor, MI and London, UK - NextGen Group plc (AIM:NGG) is pleased to announce that its US-subsidiary NextGen Sciences Inc, a leader in biomarker discovery, measurement and qualification, has launched its csfmultiplesclerosis25 multiplex protein assay for multiple sclerosis. The assay simultaneously measures 25 human CSF (cerebrospinal fluid) proteinsthat are believed to have potential as [...]
New Microbiological and Environmental Monitoring System Cuts Risk for Batch Rejection
July 27, 2011
HOPKINTON, Mass. - VelQuest Corporation, world leader in lab execution systems for the pharmaceutical industry, today introduced a new paperless microbiological environmental monitoring system for manufacturers in life science industries. SmartLab EM™ was developed in collaboration with quality control personnel at top pharmaceutical companies who were seeking a new paperless microbiological and environmental monitoring management [...]
July 27, 2011
BOULDER, Colo., and IPSWICH, Mass. - SomaLogic, Inc. and New England Biolabs, Inc. (NEB) announce today that they have entered into an exclusive licensing agreement whereby SomaLogic will provide specific SOMAmers as critical and unique reagents in several current and future NEB nucleic acid amplification and polymerase chain reaction (PCR) products. SOMAmers are specific protein [...]
Thermo Fisher Scientific Launches New LIMS for Clinical Laboratories at AACC 2011
July 27, 2011
ATLANTA – Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of a new informatics solution to support clinical laboratories serving the emerging fields of translational and personalized medicine. Thermo Scientific Clinical LIMS (laboratory information management system) is a fully functional data and sample management system that is designed to [...]
Takeda Expands Research with Genedata Expressionist for Mass Spectrometry
July 27, 2011
Tokyo, Japan - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced Takeda Pharmaceutical Company expanded its Genedata Expressionist® licensing. Takeda uses Genedata Expressionist for managing and analyzing massive amounts of mass spectrometry (MS) data for a wide variety of metabolomics and proteomics applications. With the release [...]
Record Year for CEM’s Peptide Synthesis Business
July 27, 2011
MATTHEWS, N.C. - CEM Corporation, a leading global provider of microwave laboratory instrumentation, continues to see strong success with its microwave peptide synthesis products. In FY2011 year-to-date, the company has seen significant growth versus the prior year in its automated peptide synthesizer instrument sales and is on pace to easily sell a record number of [...]
Rheonix Announces New SeptiCARD Data Demonstrating Rapid Septicemia Diagnosis
July 27, 2011
ITHACA, N.Y. - Rheonix, Inc. today announced positive results in a new application of its powerful, automated, molecular diagnostic platform, termed SeptiCARD, for the detection of septicemia, the presence of bacteria in the blood often associated with severe infection. Results were presented in a poster session at the American Association for Clinical Chemistry (AACC) Annual [...]
July 26, 2011
Franklin Lakes, NJ - The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that, in accordance with its long-term succession planning, it has elected Vincent A. Forlenza as Chief Executive Officer and President, effective October 1, 2011. Mr. Forlenza will also become a member of [...]
Thermo Fisher Scientific Expands Access to Drug Monitoring Reagents
July 26, 2011
ATLANTA -- Thermo Fisher Scientific Inc., the world leader in serving science, today announced validated applications for Thermo Scientific immunoassays on Ortho Clinical Diagnostics' VITROS® Systems. There are seven new manufacturer validated applications (MVA) which include: CEDIA® Cyclosporine Plus (including separate applications for both low and high range), CEDIA® Tacrolimus and CEDIA® Mycophenolic Acid assays [...]
